Teleflex to buy Biotronik's vascular intervention catalog for €760M

Teleflex agreed to buy substantially all of Biotronik's vascular intervention catalog for about €760 million ($791 million), including drug-coated balloons, stents, and the PK Papyrus rescue stent. The deal is expected to close by the end of Q3 2025.

“We believe the acquisition will allow us to position this advanced coronary portfolio alongside our existing Interventional business and establish our global footprint in the fast-growing peripheral intervention market.”fiercebiotech.com

• 2 sources
• fiercebiotech.comTeleflex buys Biotronic’s vascular catalog for €760M, plans company splitConor HaleFeb 27, 2025
• medicalbuyer.co.inTeleflex to acquire Biotronik’s vascular intervention biz - Medical Buyeraditya_guptaMar 3, 2025

Summarized from public sources; check the original articles before acting on it.